Differences in doxorubicin-induced apoptotic signaling in adult and immature cardiomyocytes

Free Radical Biology and Medicine

Volumn 45, Issue 12, 2008, Pages 1723-1728

  Konorev, Eugene A ^a   Vanamala, Sravan ^a   Kalyanaraman, Balaraman ^a  

^a FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Apoptosis; Cardiomyocytes; Caspases; Cytochrome c; Doxorubicin

Indexed keywords

ADENOVIRUS VECTOR; APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; CYTOCHROME C; DOXORUBICIN; PROCASPASE 9; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOTOXICITY; CELL COMMUNICATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GROUPS BY AGE; HEART MUSCLE CELL; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; APOPTOSOMES; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARRIER PROTEINS; CASPASES; CYTOCHROMES C; DOXORUBICIN; ENZYME ACTIVATION; IMMUNOBLOTTING; MALE; MITOCHONDRIAL PROTEINS; MYOBLASTS, CARDIAC; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

RATTUS;

EID: 56349128620     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.09.006     Document Type: Article

References (37)

1. Cores E.P., Holland J.F., Wang J.J., and Sinks L.F. Doxorubicin in disseminated osteosarcoma. JAMA 221 (1972) 1132-1138
2. Kenis Y., Michel J., Rimoldi R., Levy P., and Israel L. Results of a clinical trial with intermittent doses of adriamycin in lung cancer. Eur. J. Cancer 8 (1972) 485-489
3. Lefrak E.A., Pitha J., Rosenheim S., and Gottlieb J.A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32 (1973) 302-314
4. Leiper A.D. Non-endocrine late complications of bone marrow transplantation in childhood: Part I. Br. J. Haematol. 118 (2002) 3-22
5. Schwarz E.R., Pollick C., Dow J., Patterson M., Birnbaum Y., and Kloner R.A. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovasc. Res. 39 (1998) 216-223
6. Konorev E.A., Kennedy M.C., and Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates. Arch. Biochem. Biophys. 368 (1999) 421-428
7. Lebrecht D., Setzer B., Ketelson U.-P., Haberstroh J., and Walker U. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 108 (2003) 2423-2429
8. Sawyer D.B., Zuppinger C., Miller M.A., Eppenberger H.M., and Suter T.M. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1β and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity. Circulation 105 (2002) 1551-1554
9. Ito H., Miller S.C., Billingham M.E., Akioto H., Torti S.V., Wade R., Gahlmann R., Lyons G., Kedes L., and Torti F.M. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc. Natl. Acad. Sci. USA 87 (1990) 4275-4279
10. Sawyer D.B., Fukuzawa R., Arstall M.A., and Kelly R.A. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ. Res. 84 (1999) 257-265
11. Kotamraju S., Konorev E.A., Joseph J., and Kalyanaraman B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J. Biol. Chem. 275 (2000) 33585-33592
12. Konorev E.A., Kotamraju S., Zhao H., Kalivendi S., Joseph J., and Kalyanaraman B. Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: scavenging of reactive oxygen species versus induction of heme oxygenase-1. Free Radic. Biol. Med. 33 (2002) 988-997
13. Fisher P.W., Salloum F., Das A., Hyder H., and Kukreja R.C. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiomyopathy. Circulation 111 (2005) 1601-1610
14. Komarova E.A., Chernov M.V., Franks R., Wang K., Armin G., Zelnick C.R., Chin D.M., Bacus S.S., Stark G.R., and Gudkov A.V. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J. 16 (1997) 1391-1400
15. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
16. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlecher M.J., Adams J.M., and Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa. Science 302 (2003) 1036-1038
17. Tinel A., and Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304 (2004) 843-846
18. Fulda S., Meyer E., Friesen C., Susin S.A., Kroemer G., and Debatin K.M. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 20 (2001) 1063-1075
19. Cui H., Schroering A., and Ding H.F. p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol. Cancer Ther. 1 (2002) 679-686
20. Konorev E.A., Zhang H., Joseph J., Kennedy M.C., and Kalyanaraman B. Bicarbonate exacerbates oxidative injury induced by antitumor antibiotic doxorubicin in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H2424-H2430
21. Antos C.L., McKinsey T.A., Dreitz M., Hollingsworth L.M., Zhang C.L., Schreiber K., Rindt H., Gorczysnki R.J., and Olson E.N. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278 (2003) 28930-28937
22. Veksler V.I., Kuznetsov A.V., Sharov V.G., Kapelko V.I., and Saks V.A. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment using saponin-skinned fibers. Biochim. Biophys. Acta 892 (1987) 191-196
23. Lehman J.J., Barger P.M., Kovacs A., Saffitz J.E., Medeiros D.M., and Kelly D.P. Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106 (2000) 847-856
24. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
25. Sparagna G.C., Hickson-Bick D.L., Buja L.M., and McMillin J.B. A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H2124-H2132
26. Iordanov M.S., Ryabinina O.P., Schneider P., and Magun B.E. Two mechanisms of caspase-9 processing in double-stranded RNA- and virus-triggered apoptosis. Apoptosis 10 (2005) 153-166
27. Mueller T., Voigt W., Simon H., Fruehauf A., Bulankin A., Grothey A., and Schmoll H.J. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res. 63 (2003) 513-521
28. Shinoura N., Sakarai S., Asai A., Kirino T., and Hamada H. Co-transduction of Apaf-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells. Jpn. J. Cancer Res. 92 (2001) 467-474
29. Hill M.M., Adrain C., Duriez P.J., Creagh E.M., and Martin S.J. Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J. 23 (2004) 2134-2145
30. Burgess D.H., Svensson M., Dandrea T., Gronlund K., Hammarquist F., Orrenius S., and Cotgreave I.A. Human skeletal muscle cytosols are refractory to cytochrome c-dependent activation of type II-caspases and lack Apaf-1. Cell Death Differ. 6 (1999) 256-261
31. Yakovlev A.G., Ota K., Wang G., Movsesyan V., Bao W.L., Yoshihara K., and Faden A.L. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J. Neurosci. 21 (2001) 7439-7446
32. Takatani T., Takahashi K., Uozumi Y., Shikata E., Yamamoto Y., Ito T., Matsuda T., Schaffer S.W., Fujio Y., and Azuma J. Taurine inhibits apoptosis by preventing formation of Apaf-1/caspase-9 apoptosome. Am. J. Physiol. Cell Physiol. 287 (2004) C949-C953
33. Sanchis D., Mayorga M., Ballester M., and Comella J.X. Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes. Cell Death Differ. 10 (2003) 977-986
34. Kimes B.W., and Brandt B.L. Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98 (1976) 367-381
35. Menard C., Pupier S., Mornet D., Kitzmann M., Nargeot J., and Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9c2 cardiac cells. J. Biol. Chem. 274 (1999) 29063-29070
36. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
37. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., Entman M.L., and Schneider M.D. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100 (2003) 12313-12318